This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Janssen Biotech, Inc., Centocor Ortho Biotech Inc., Centocor, Inc.. Active years: 2009-2024.
Location History:
- Cleveland, OH (US) (2015)
- Spring House, PA (US) (2015)
- North Wales, PA (US) (2009 - 2021)
Company Filing History:
9 out of 433 
1 out of 31 
1 out of 144 
Years Active: 2009-2024
Title: Cynthia Duchala: Innovator in Anti-IL-23 Antibodies
Introduction
Cynthia Duchala is a prominent inventor based in North Wales, PA (US), known for her significant contributions to the field of biotechnology. With a total of 11 patents to her name, she has made remarkable advancements in the development of anti-IL-23 antibodies.
Latest Patents
Cynthia's latest patents focus on anti-IL-23 antibodies, which include isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using these antibodies. These innovations have applications in diagnostic and therapeutic compositions, methods, and devices, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Cynthia has worked with notable companies such as Janssen Biotech, Inc. and Centocor, Inc. Her work in these organizations has allowed her to develop groundbreaking technologies that address critical health issues.
Collaborations
Cynthia has collaborated with esteemed colleagues, including Mark Hilary Cunningham and Jill M Giles-Komar, further enhancing her research and innovation efforts.
Conclusion
Cynthia Duchala's contributions to the field of biotechnology, particularly in the development of anti-IL-23 antibodies, highlight her role as a leading inventor. Her work continues to impact the medical community positively.